by Insception Lifebank | Blog, blood cancer, cord blood application, FDA, Health and Wellness, Research
The FDA made history in April with its first-ever approval of an expanded cord blood product for use as a primary treatment in hematopoietic stem cell transplants (HSCT) for certain blood cancers in adults and children 12 years of age and older.1 Why is cord blood...
by Insception Lifebank | Blog, blood cancer, cord blood application, FDA, Health and Wellness, Research
Share this article : “Wait! Wait! Wait! I have something for you.” What that nurse at the ultrasound center had for expecting mom Jessica Fox was a CBR®, our American sister company’s brochure. Just weeks after learning she was pregnant with their first child,...
Sign in 